{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:28:30Z","timestamp":1786588110798,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Michael G. DeGroote School of Medicine, McMaster University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Caffeine citrate is recommended to treat apnea of prematurity in premature neonates based on high-quality evidence demonstrating improved outcomes. In contrast, the prescription of caffeine for mature neonates and infants hospitalized with apnea is based on a paucity of evidence. We present here our protocol for a systematic review to synthesize existing data on the safety and effectiveness of caffeine treatment for apnea in hospitalized pediatric patients, with findings expected to focus on mature neonates and infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed this systematic review protocol in accordance with the PRISMA guidelines and PRISMA-P checklist. The search strategy was developed with the assistance of an information specialist. Information sources will include MEDLINE, Embase, CINAHL, and CENTRAL databases, as well as unpublished literature sources. Eligible studies will include randomized controlled trials, non-randomized trials, and observational studies investigating caffeine (of any formulation, administered by any route, of any duration) versus placebo, usual care, or non-methylxanthine comparator. The population of interest is children aged 0\u201317\u00a0years with apnea presenting to emergency, critical care, or in-patient settings; studies of premature babies receiving treatment for apnea of prematurity will be excluded. Critical outcomes include total duration of respiratory support, ventilator-free days, duration of invasive mechanical ventilation, duration of non-invasive respiratory support, time to apnea cessation, and serious adverse events. Two authors will independently screen identified studies against prespecified eligibility criteria. Data from included studies will be abstracted in duplicate and entered into our data abstraction form. Risk of bias for each included study will be independently assessed by two reviewers using the appropriate risk of bias tool. If appropriate, we will perform a meta-analysis. The quality of evidence will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, with results presented in a summary of findings table.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We will undertake the first rigorous evidence synthesis examining the safety and efficacy of caffeine treatment for apnea in hospitalized pediatric patients, where studies of premature babies with apnea of prematurity will be specifically excluded. We aim to fill the identified knowledge gap with this systematic review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO CRD420251146484.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-026-03222-w","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:46:14Z","timestamp":1780929974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Caffeine treatment for apnea in infants and children: protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Michelle","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitryn","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Zorko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-9296","authenticated-orcid":false,"given":"Melissa J.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"20","key":"3222_CR1","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354(20):2112\u201321.","journal-title":"N Engl J Med"},{"issue":"4","key":"3222_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/pr.1991.72500","volume":"29","author":"K Barrington","year":"1991","unstructured":"Barrington K, Finer N. The natural history of the appearance of apnea of prematurity. Pediatr Res. 1991;29(4):372\u20135.","journal-title":"Pediatr Res"},{"issue":"12","key":"3222_CR3","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.jp.7211182","volume":"24","author":"A Janvier","year":"2004","unstructured":"Janvier A, Khairy M, Kokkotis A, Cormier C, Messmer D, Barrington KJ. Apnea is associated with neurodevelopmental impairment in very low birth weight infants. J Perinatol. 2004;24(12):763\u20138.","journal-title":"J Perinatol"},{"issue":"1","key":"3222_CR4","volume":"14","author":"J Pergolizzi","year":"2022","unstructured":"Pergolizzi J, Kraus A, Magnusson P, Breve F, Mitchell K, Raffa R, et al. Treating apnea of prematurity. Cureus. 2022;14(1):e21783.","journal-title":"Cureus"},{"issue":"4","key":"3222_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.siny.2017.04.003","volume":"22","author":"ME Patrinos","year":"2017","unstructured":"Patrinos ME, Martin RJ. Apnea in the term infant. Semin Fetal Neonatal Med. 2017;22(4):240\u20134.","journal-title":"Semin Fetal Neonatal Med"},{"key":"3222_CR6","unstructured":"Pappano DA. Respiratory Virus-Associated Apnea. Clinician.com. 12(1):1\u201312."},{"issue":"5","key":"3222_CR7","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-0590","volume":"137","author":"JS Tieder","year":"2016","unstructured":"Tieder JS, Bonkowsky JL, Etzel RA, Franklin WH, Gremse DA, Herman B, et al. Brief resolved unexplained events (formerly apparent life-threatening events) and evaluation of lower-risk infants. Pediatrics. 2016;137(5):e20160590.","journal-title":"Pediatrics"},{"issue":"3","key":"3222_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ccr3.765","volume":"5","author":"M Ochi","year":"2017","unstructured":"Ochi M, Nosaka N, Knaup E, Tsukahara K, Kikkawa T, Fujii Y, et al. Recurrent apnea in an infant with pertussis due to household transmission. Clin Case Rep. 2017;5(3):241\u20135.","journal-title":"Clin Case Rep"},{"issue":"3","key":"3222_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1128\/CMR.00083-15","volume":"29","author":"PE Kilgore","year":"2016","unstructured":"Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev. 2016;29(3):449\u201386.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"3222_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.arcped.2019.10.009","volume":"27","author":"N Heuz\u00e9","year":"2020","unstructured":"Heuz\u00e9 N, Goyer I, Porcheret F, Denis M, Faucon C, Jokic M, et al. Caffeine treatment for bronchiolitis-related apnea in the pediatric intensive care unit. Arch Pediatr. 2020;27(1):18\u201323.","journal-title":"Arch Pediatr"},{"issue":"5","key":"3222_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/ppul.21389","volume":"46","author":"T Principi","year":"2011","unstructured":"Principi T, Fraser DD, Morrison GC, Farsi SA, Carrelas JF, Maurice EA, et al. Complications of mechanical ventilation in the pediatric population. Pediatr Pulmonol. 2011;46(5):452\u20137.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"3222_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/PCC.0000000000001476","volume":"19","author":"JC Manning","year":"2018","unstructured":"Manning JC, Pinto NP, Rennick JE, Colville G, Curley MAQ. Conceptualizing Post Intensive Care Syndrome in Children-The PICS-p framework. Pediatr Crit Care Med. 2018;19(4):298\u2013300.","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"3222_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"},{"issue":"349","key":"3222_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","volume":"2","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;2(349):g7647.","journal-title":"BMJ"},{"issue":"142","key":"3222_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jclinepi.2021.11.026","volume":"1","author":"CA Cuello-Garcia","year":"2022","unstructured":"Cuello-Garcia CA, Santesso N, Morgan RL, Verbeek J, Thayer K, Ansari MT, et al. GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines. J Clin Epidemiol. 2022;1(142):200\u20138.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"3222_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2352-4642(24)00303-1","volume":"9","author":"LJ Schlapbach","year":"2025","unstructured":"Schlapbach LJ, Ramnarayan P, Gibbons KS, Morrow BM, Napolitano N, Tume LN, et al. Building global collaborative research networks in paediatric critical care: a roadmap. Lancet Child Adolesc Health. 2025;9(2):138\u201350.","journal-title":"Lancet Child Adolesc Health"},{"issue":"366","key":"3222_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366):l4898.","journal-title":"BMJ"},{"key":"3222_CR18","unstructured":"Risk of bias tools - ROBINS-I V2 tool. Available from: https:\/\/www.riskofbias.info\/welcome\/robins-i-v2. Cited 2025 Sep 18."},{"issue":"372","key":"3222_CR19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29(372):n71.","journal-title":"BMJ"},{"issue":"372","key":"3222_CR20","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;29(372):n160.","journal-title":"BMJ"},{"issue":"1","key":"3222_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"key":"3222_CR22","unstructured":"The Cochrane Collaboration. Review Manager (RevMan). 2024. Available from: revman.cochrane.org"},{"key":"3222_CR23","volume-title":"Cochrane handbook for systematic reviews of interventions","year":"2024","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al editors. Cochrane handbook for systematic reviews of interventions. version 6.5. Cochrane; 2024.","edition":"version 6.5"},{"key":"3222_CR24","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, editors. Chapter 10: Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions. version 6.5. Available from: http:\/\/www.cochrane.org\/handbook. Cited 2026 Feb 13."},{"issue":"32","key":"3222_CR25","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/cmaj.200077","volume":"192","author":"S Schandelmaier","year":"2020","unstructured":"Schandelmaier S, Briel M, Varadhan R, Schmid CH, Devasenapathy N, Hayward RA, et al. Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses. CMAJ. 2020;192(32):E901\u20136.","journal-title":"CMAJ"},{"issue":"7109","key":"3222_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"7650","key":"3222_CR27","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"3","key":"3222_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","volume":"22","author":"MH Murad","year":"2017","unstructured":"Murad MH, Mustafa RA, Sch\u00fcnemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85\u20137.","journal-title":"Evid Based Med"},{"issue":"119","key":"3222_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","volume":"1","author":"N Santesso","year":"2020","unstructured":"Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;1(119):126\u201335.","journal-title":"J Clin Epidemiol"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-026-03222-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03222-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-026-03222-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T02:06:32Z","timestamp":1786586792000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-026-03222-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3222"],"URL":"https:\/\/doi.org\/10.1186\/s13643-026-03222-w","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not required for a systematic review.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for a systematic review.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"221"}}